Latest News
Sunday share tips: Royal Mail Group, Digital 9 Infrastructure
The Sunday Times's Sabah Meddings told readers to 'buy' shares of Royal Mail Group.
Sunday newspaper round-up: Pfizer, GlaxoSmithKline, Rolls-Royce
Pfizer’s most senior UK executive has criticised the call to forgo patents on Covid vaccines, warning that it would lead to a global shortage of raw materials. Ben Osborn, who leads the American drugs giant in the UK, said an intellectual-property waiver was “not the answer”. “We would see a very rapid short-term impact,” he said. “It could allow any organisation to start procuring some of these basic raw materials across multiple countries. ” Osborn, 44, said it could even mean that existing vaccine manufacturers — which include Astra Zeneca and US biotech venture Moderna — would be unable to fulfil their obligations to deliver doses.